Trademark: ONCOCOMPLETE 2387232
Word
ONCOCOMPLETE
ID
2387232
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
08 September 2023
Registration Date
08 September 2023
Renewal Date
08 September 2033
Owner(s)
Service
K&L Gates
Goods and Services:
Class 41:
Providing non-downloadable videos and publications in the nature of newsletters and articles in the field of cancer via a website; Providing non-downloadable educational videos and webcasts in the field of cancer via a website
Providing non-downloadable videos and publications in the nature of newsletters and articles in the field of cancer via a website; Providing non-downloadable educational videos and webcasts in the field of cancer via a website
Class 42:
Platform as a service (PAAS) services featuring a computer software platform that allows patients to communicate with healthcare providers, doctors, and physicians, access on-demand phone support, and receive reminder phone calls, texts and emails in the field of cancer screening, pre-cancer screening, cancer diagnostic testing, disease or pre-disease detection, monitoring or surveillance; Providing temporary online use of non-downloadable software for use by physicians for use in collecting, requesting, managing, analyzing and comparing medical information, patient records, patient laboratory orders, patient tests and analysis; Hosting an online website portal featuring technology that allows users to register and access the test results associated with medical and diagnostic test kits for detecting cancer; all of the foregoing for use in the field of cancer diagnostics, prognostics and treatment recommendations
Platform as a service (PAAS) services featuring a computer software platform that allows patients to communicate with healthcare providers, doctors, and physicians, access on-demand phone support, and receive reminder phone calls, texts and emails in the field of cancer screening, pre-cancer screening, cancer diagnostic testing, disease or pre-disease detection, monitoring or surveillance; Providing temporary online use of non-downloadable software for use by physicians for use in collecting, requesting, managing, analyzing and comparing medical information, patient records, patient laboratory orders, patient tests and analysis; Hosting an online website portal featuring technology that allows users to register and access the test results associated with medical and diagnostic test kits for detecting cancer; all of the foregoing for use in the field of cancer diagnostics, prognostics and treatment recommendations
Class 44:
Providing medical information to medical professionals and healthcare providers in the form of reports in the field of cancer screening, diagnostics, prognostics and treatment; Providing information to patients in the field of medical diagnostic screening; Providing medical information in the field of cancer awareness; Providing information in the field of prevention, screening, diagnosis, and treatment of cancer; Providing information to patients, medical professionals and healthcare providers in the field of medical diagnostic screening; Providing medical information; Providing medical information via a website; Providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing in the field of cancer; Providing genomic and genetic testing for medical purposes in the field of cancer; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer; Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes and copy number variations for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancer
Providing medical information to medical professionals and healthcare providers in the form of reports in the field of cancer screening, diagnostics, prognostics and treatment; Providing information to patients in the field of medical diagnostic screening; Providing medical information in the field of cancer awareness; Providing information in the field of prevention, screening, diagnosis, and treatment of cancer; Providing information to patients, medical professionals and healthcare providers in the field of medical diagnostic screening; Providing medical information; Providing medical information via a website; Providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing in the field of cancer; Providing genomic and genetic testing for medical purposes in the field of cancer; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer; Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes and copy number variations for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancer